Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jun Iwamoto

Showing results (171-180 of 200) with videos related to

Pageof 20
Sort By:
Calcified Tissue International|January 30, 2010
Vitamin K2 promotes bone healing in a rat femoral osteotomy model with or without glucocorticoid treatmentJun Iwamoto, Azusa Seki, Yoshihiro Sato, et al.
The Chinese Journal of Physiology|October 22, 2008
Effects of combined administration of alfacalcidol and risedronate on cancellous and cortical bone mass of the tibia in glucocorticoid-treated young ratsJun Iwamoto, Azusa Seki, Tsuyoshi Takeda, et al.
The Chinese Journal of Physiology|March 14, 2009
Effects of alendronate and alfacalcidol on the femoral bone mass and bone strength in orchidectomized ratsJun Iwamoto, Hideo Matsumoto, Tsuyoshi Takeda, et al.
Calcified Tissue International|December 8, 2010
Vitamin K₂ prevents hyperglycemia and cancellous osteopenia in rats with streptozotocin-induced type 1 diabetesJun Iwamoto, Azusa Seki, Yoshihiro Sato, et al.
Experimental Animals|July 31, 2018
Retraction: Therapeutic effect of risedronate on cancellous and cortical bone in ovariectomized osteopenic rats: a comparison with the effects of alfacalcidolJun Iwamoto, Azusa Seki, Tsuyoshi Takeda, et al.
Experimental Animals|July 31, 2018
Retraction: Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized ratsJun Iwamoto, Azusa Seki, Tsuyoshi Takeda, et al.
Journal of Nutritional Science and Vitaminology|September 19, 2007
Effects of alfacalcidol on cancellous and cortical bone mass in rats treated with glucocorticoid: a bone histomorphometry studyJun Iwamoto, Azusa Seki, Tsuyoshi Takeda, et al.
Journal of Nutritional Science and Vitaminology|April 28, 2006
Comparative therapeutic effects of alendronate and alfacalcidol on cancellous and cortical bone mass and mechanical properties in ovariectomized osteopenic ratsJun Iwamoto, Azusa Seki, Tsuyoshi Takeda, et al.
Journal of Bone and Mineral Metabolism|January 21, 2014
Survey of the utility of once-monthly bisphosphonate treatment for improvement of medication adherence in osteoporosis patients in JapanKazuya Makita, Hiroya Okano, Takefumi Furuya, et al.
The Kurume Medical Journal|July 23, 2011
The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trialYoshihiro Sato, Yoshiaki Honda, Kazuo Umeno, et al.
Pageof 20

Showing results (171-180 of 200) with videos related to

Sort By:
Pageof 20
Calcified Tissue International|January 30, 2010
Vitamin K2 promotes bone healing in a rat femoral osteotomy model with or without glucocorticoid treatmentJun Iwamoto, Azusa Seki, Yoshihiro Sato, et al.
The Chinese Journal of Physiology|October 22, 2008
Effects of combined administration of alfacalcidol and risedronate on cancellous and cortical bone mass of the tibia in glucocorticoid-treated young ratsJun Iwamoto, Azusa Seki, Tsuyoshi Takeda, et al.
The Chinese Journal of Physiology|March 14, 2009
Effects of alendronate and alfacalcidol on the femoral bone mass and bone strength in orchidectomized ratsJun Iwamoto, Hideo Matsumoto, Tsuyoshi Takeda, et al.
Calcified Tissue International|December 8, 2010
Vitamin K₂ prevents hyperglycemia and cancellous osteopenia in rats with streptozotocin-induced type 1 diabetesJun Iwamoto, Azusa Seki, Yoshihiro Sato, et al.
Experimental Animals|July 31, 2018
Retraction: Therapeutic effect of risedronate on cancellous and cortical bone in ovariectomized osteopenic rats: a comparison with the effects of alfacalcidolJun Iwamoto, Azusa Seki, Tsuyoshi Takeda, et al.
Experimental Animals|July 31, 2018
Retraction: Comparative effects of alendronate and alfacalcidol on cancellous and cortical bone mass and bone mechanical properties in ovariectomized ratsJun Iwamoto, Azusa Seki, Tsuyoshi Takeda, et al.
Journal of Nutritional Science and Vitaminology|September 19, 2007
Effects of alfacalcidol on cancellous and cortical bone mass in rats treated with glucocorticoid: a bone histomorphometry studyJun Iwamoto, Azusa Seki, Tsuyoshi Takeda, et al.
Journal of Nutritional Science and Vitaminology|April 28, 2006
Comparative therapeutic effects of alendronate and alfacalcidol on cancellous and cortical bone mass and mechanical properties in ovariectomized osteopenic ratsJun Iwamoto, Azusa Seki, Tsuyoshi Takeda, et al.
Journal of Bone and Mineral Metabolism|January 21, 2014
Survey of the utility of once-monthly bisphosphonate treatment for improvement of medication adherence in osteoporosis patients in JapanKazuya Makita, Hiroya Okano, Takefumi Furuya, et al.
The Kurume Medical Journal|July 23, 2011
The prevention of hip fracture with menatetrenone and risedronate plus calcium supplementation in elderly patients with Alzheimer disease: a randomized controlled trialYoshihiro Sato, Yoshiaki Honda, Kazuo Umeno, et al.
Pageof 20